16.45
-0.18 (-1.08%)
-0.18 (-1.08%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spero Therapeutics Inc | SPRO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.18 | -1.08% | 16.45 | 00:00:10 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.57 | 16.17 | 17.00 | 16.45 | 16.63 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 14.91 | 21.50 | 6.59 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,436 | 239,375 | $ 16.61 | $ 3,976,264 | 389,729 | 5.25 - 23.639 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:05:57 | 10 | $ 16.91 | USD |
Spero Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 447.39M | 27.20M | 24.63M | $ 18.15M | $ - | -3.32 | -3.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Spero Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.50 | 17.57 | 15.82 | 16.43 | 231,761 | -1.05 | -6.0% |
| 1 Month | 18.75 | 23.639 | 15.82 | 18.70 | 442,387 | -2.30 | -12.27% |
| 3 Months | 14.18 | 23.639 | 12.73 | 17.11 | 313,641 | 2.27 | 16.01% |
| 6 Months | 13.74 | 23.639 | 8.50 | 13.98 | 320,212 | 2.71 | 19.72% |
| 1 Year | 9.03 | 23.639 | 5.25 | 13.03 | 231,311 | 7.42 | 82.17% |
| 3 Years | 12.30 | 23.639 | 5.25 | 12.31 | 125,094 | 4.15 | 33.74% |
| 5 Years | 13.25 | 23.639 | 5.25 | 12.28 | 124,747 | 3.20 | 24.15% |
Spero Therapeutics Description
| Spero Therapeutics Inc is a US-based clinical-stage biopharmaceutical company. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections. The company's product candidate, SPR994, is designed as a broad-spectrum oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It has developed platform technology known as Potentiator Platform to develop drugs to expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. In addition, the company is developing SPR720, an oral antibiotic designed for the treatment of pulmonary non-tuberculous mycobacterial infections. The pipeline products include SPR741, SPR206, and SPR720. |
